TIANXIN PHARMA: Net profit of 651 million yuan in 2024, a year-on-year increase of 36.85%

TIANXIN PHARMA announced that the operating revenue for 2024 is 2.209 billion yuan, a year-on-year increase of 17.35%. The net profit attributable to shareholders of the listed company is 651 million yuan, a year-on-year increase of 36.85%. The company plans to distribute a cash dividend of 0.68 yuan per share to all shareholders